BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 12430671)

  • 1. Transfusion transmission of HCV infection before anti-HCV testing of blood donations in England: results of the national HCV lookback program.
    Transfusion; 2002 Sep; 42(9):1146-53. PubMed ID: 12430671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probability of receiving testing in a national lookback program: the English HCV experience.
    Transfusion; 2002 Sep; 42(9):1140-5. PubMed ID: 12430670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of an optional HCV screening program for blood transfusion recipients in Ireland.
    Davoren A; Dillon AD; Power JP; Donnellan J; Quinn JM; Willis JW; Lawlor EM; O'Riordan JM
    Transfusion; 2002 Nov; 42(11):1501-6. PubMed ID: 12421225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of a hepatitis C general transfusion lookback program for patients who received blood products before July 1992.
    Williams JL; Cagle HH; Christensen CJ; Fox-Leyva LK; McMahon BJ
    Transfusion; 2005 Jun; 45(6):1020-6. PubMed ID: 15935002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent Canadian experience with targeted hepatitis C virus lookback.
    Goldman M; Patterson L; Long A
    Transfusion; 2006 May; 46(5):690-4. PubMed ID: 16686835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of hepatitis C infection in neonates transfused with blood from donors infected with hepatitis C.
    O'Riordan JM; Conroy A; Nourse C; Yap PL; McDonald GS; Kaminski G; Leong K; Lawlor E; Davoren A; Strong K; Davidson F; Lloyd A; Power J
    Transfus Med; 1998 Dec; 8(4):303-8. PubMed ID: 9881424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C lookback programme: a single hospital experience.
    Pawson R; Rajan S; Hazlehurst G; Dusheiko G; Miller R; Hewitt P; Mehta A
    Transfus Med; 1999 Sep; 9(3):189-93. PubMed ID: 10555811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The contribution of transfusion to HCV infection in England.
    Soldan K; Ramsay M; Robinson A; Harris H; Anderson N; Caffrey E; Chapman C; Dike A; Gabra G; Gorman A; Herborn A; Hewitt P; Hewson N; Jones DA; Llewelyn C; Love E; Muddu V; Martlew V; Townley A
    Epidemiol Infect; 2002 Dec; 129(3):587-91. PubMed ID: 12558342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transfusion-acquired hepatitis C: the Danish lookback experience. The Danish HCV [hepatitis C virus] Lookback Group.
    Christensen PB; Groenbaek K; Krarup HB
    Transfusion; 1999 Feb; 39(2):188-93. PubMed ID: 10037130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Significance of alanine aminotransferase screening in blood donors for risk reduction of hepatitis B and C transmission by haemotherapy].
    Kusendová K; Gavorník P; Sabaka P; Sviteková K
    Vnitr Lek; 2016 Jan; 62(1):9-16. PubMed ID: 26967232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Routine HCV PCR screening of blood donations to identify early HCV infection in blood donors lacking antibodies to HCV.
    Hitzler WE; Runkel S
    Transfusion; 2001 Mar; 41(3):333-7. PubMed ID: 11274586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of a general hepatitis C lookback program for persons who received blood transfusions in a neonatal intensive care unit between January 1975 and July 1992.
    Cagle HH; Jacob J; Homan CE; Williams JL; Christensen CJ; McMahon BJ
    Arch Pediatr Adolesc Med; 2007 Feb; 161(2):125-30. PubMed ID: 17283296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PCR testing for HCV in anti-HCV negative blood donors involved in the so called HCV +ve post-transfusion hepatitis.
    Ruzzenenti MR; De Luigi MC; Bruni R; Giannini G; Bo A; Valbonesi M; Barresi R; Torretta F; Gianotti P; Bruzzone B
    Transfus Sci; 2000 Jun; 22(3):161-4. PubMed ID: 10831918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low incidence of non-A, non-B post-transfusion hepatitis in London confirmed by hepatitis C virus serology.
    Contreras M; Barbara JA; Anderson CC; Ranasinghe E; Moore C; Brennan MT; Howell DR; Aloysius S; Yardumian A
    Lancet; 1991 Mar; 337(8744):753-7. PubMed ID: 1672391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Discovery of a chronic HVC infection without seroconversion in a blood donor in France during 28 months].
    Durand F; Danic B; Tardivel R; Semana G; Gouezec H; Martinot M; Marcellin P; Beauplet A
    Transfus Clin Biol; 2000 Jun; 7(3):242-50. PubMed ID: 10919211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C lookback in Canada.
    Goldman M; Long A
    Vox Sang; 2000; 78 Suppl 2():249-52. PubMed ID: 10938962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis E virus in blood components: a prevalence and transmission study in southeast England.
    Hewitt PE; Ijaz S; Brailsford SR; Brett R; Dicks S; Haywood B; Kennedy IT; Kitchen A; Patel P; Poh J; Russell K; Tettmar KI; Tossell J; Ushiro-Lumb I; Tedder RS
    Lancet; 2014 Nov; 384(9956):1766-73. PubMed ID: 25078306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection.
    Conry-Cantilena C; VanRaden M; Gibble J; Melpolder J; Shakil AO; Viladomiu L; Cheung L; DiBisceglie A; Hoofnagle J; Shih JW
    N Engl J Med; 1996 Jun; 334(26):1691-6. PubMed ID: 8637513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transmission of hepatitis C virus by transfusion in Orebro County, Sweden, 1990-1992.
    Norda R; Duberg AS; Sönnerborg A; Olcén P
    Scand J Infect Dis; 1995; 27(5):449-52. PubMed ID: 8588133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C virus (HCV) infection in bone marrow transplant patients after transfusions from anti-HCV-positive blood donors.
    Shuhart MC; Myerson D; Spurgeon CL; Bevan CA; Sayers MH; McDonald GB
    Bone Marrow Transplant; 1996 Apr; 17(4):601-6. PubMed ID: 8722362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.